Vitamin K epoxide reductase regulation of androgen receptor activity

Long-term use of warfarin has been shown to be associated with a reduced risk of prostate cancer. Warfarin belongs to the vitamin K antagonist class of anticoagulants, which inhibit vitamin K epoxide reductase (VKOR). The vitamin K cycle is primarily known for its role in γ-carboxylation, a rare pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Tew, Ben Yi, Hong, Teresa B., Otto-Duessel, Maya, Elix, Catherine, Castro, Egbert, He, Miaoling, Wu, Xiwei, Pal, Sumanta K., Kalkum, Markus, Jones, Jeremy O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355141/
https://www.ncbi.nlm.nih.gov/pubmed/28099154
http://dx.doi.org/10.18632/oncotarget.14639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355141/
https://www.ncbi.nlm.nih.gov/pubmed/28099154
http://dx.doi.org/10.18632/oncotarget.14639

Ejemplares similares